These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 703513)

  • 21. Equal antiplatelet effects of aspirin 50 or 324 mg/day in patients after acute myocardial infarction.
    De Caterina R; Giannessi D; Boem A; Bernini W; Battaglia D; Michelassi C; Dell'Amico F; L'Abbate A; Patrignani P; Patrono C
    Thromb Haemost; 1985 Aug; 54(2):528-32. PubMed ID: 4082090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of eterylate on "in vitro" Platelet function in human plasma (author's transl)].
    Ortega MP; Priego JG; Sunkel C; Armijo M
    Arch Farmacol Toxicol; 1980 Apr; 6(1):31-40. PubMed ID: 6104474
    [No Abstract]   [Full Text] [Related]  

  • 23. Iron-induced platelet aggregation measurement: a novel method to measure platelet function in stenting for ST segment elevation myocardial infarction.
    Smit JJ; van Oeveren W; Ottervanger JP; Slingerland RJ; Remijn JA; Zijlstra F; van 't Hof AW
    Eur J Clin Invest; 2009 Feb; 39(2):103-9. PubMed ID: 19200163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of bencyclan on shear induced platelet aggregation (author's transl)].
    Klose HJ; Rieger H; Schmid-Schönbein H
    Arzneimittelforschung; 1975 Jul; 25(7):1064-7. PubMed ID: 1174412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical importance of laboratory-defined aspirin resistance in patients presenting with non-ST elevation acute coronary syndromes.
    Acikel S; Yildirir A; Aydinalp A; Bal U; Kaynar G; Ozin B; Muderrisoglu H
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):427-32. PubMed ID: 19542882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [On the platelet aggregation inhibiting and analgesic activities of acetylsalicylic acid (author's transl)].
    Schnell O; Lang E; Bertholdt H
    Arzneimittelforschung; 1980; 30(11):1917-22. PubMed ID: 7193003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Aspirin as a platelet antiaggregant: indications and controversies].
    Stalder M; Bachmann F
    Ther Umsch; 1987 Aug; 44(8):584-90. PubMed ID: 3313789
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical pharmacology of acetylsalicylic acid].
    Schröder H; Schrör K
    Z Kardiol; 1992; 81 Suppl 4():171-5. PubMed ID: 1290295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spontaneous platelet aggregation in arterial insufficiency: mechanisms and implications.
    Wu KK; Hoak JC
    Thromb Haemost; 1976 Jun; 35(3):702-11. PubMed ID: 989974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of various drugs on microaggregate formation in endotoxin shock (author's transl)].
    Saito K; Siow C; Endo T; Kou SZ; Araki E; Suzuki M; Okuaki A
    Masui; 1979 Nov; 28(12):1536-42. PubMed ID: 231123
    [No Abstract]   [Full Text] [Related]  

  • 31. Platelet function and response to aspirin: gender-specific features and implications for female thrombotic risk and management.
    Zuern CS; Lindemann S; Gawaz M
    Semin Thromb Hemost; 2009 Apr; 35(3):295-306. PubMed ID: 19452405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Arachidonic acid metabolism and platelet function in diabetics (author's transl)].
    Amado Señaris JA; Garcia-Conde Bru J; Merino Sanchez J; Benet Monforte I
    Sangre (Barc); 1981; 26(3):351-9. PubMed ID: 6794160
    [No Abstract]   [Full Text] [Related]  

  • 33. [Thrombocyte function and the repair of myocardial infarct].
    Kinoshenko EI; Aliavi AL; Vlasenko MA
    Vrach Delo; 1989 Jan; (1):27-9. PubMed ID: 2718437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Influence of acute exertion and physical training on platelet function of the coronary patient].
    Broustet JP; Boisseau M; Bouloumie J; Emeriau JP; Bricaud H
    Arch Mal Coeur Vaiss; 1976 Mar; 69(3):305-13. PubMed ID: 828016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of prostacycline, thromboxane A2 and prostaglandins in platelet aggregation (author's transl)].
    Herman AG
    Rev Med Brux; 1981 Mar; 2(3):251-7. PubMed ID: 7015444
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of acetylsalicylic acid on the indicators of thrombocytic hemostasis in patients with myocardial infarction].
    Sidorenko BA; Botolova EN; Golikova AA; Gruzdev AK; Sergienko IV
    Kardiologiia; 1992 Jan; 32(1):41-3. PubMed ID: 1614019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preventing death after myocardial infarction.
    Horwitz DL
    Compr Ther; 1980 Jun; 6(6):3-4. PubMed ID: 7379491
    [No Abstract]   [Full Text] [Related]  

  • 38. Platelet disaggregation: putting time on your side in acute myocardial infarction.
    Simon DI; Sakuma M
    J Am Coll Cardiol; 2004 Jul; 44(2):324-6. PubMed ID: 15261926
    [No Abstract]   [Full Text] [Related]  

  • 39. Erythrocyte deformability and white blood cell count are associated with aspirin resistance in high-risk vascular patients.
    Mannini L; Marcucci R; Paniccia R; Antonucci E; Giglioli C; Valente S; Gori AM; Prisco D; Gensini GF; Abbate R
    Clin Hemorheol Microcirc; 2006; 35(1-2):175-81. PubMed ID: 16899924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biphasic initial phase of platelet aggregation inhibition after oral aspirin.
    Walter E; Zimmermann R; Siess R; Staiger C; Weber E
    Artery; 1980; 8(5):501-6. PubMed ID: 7213053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.